Quarterly report pursuant to Section 13 or 15(d)

Fair Value Measurements

v3.22.2
Fair Value Measurements
6 Months Ended
Jun. 30, 2022
Fair Value Measurements [Abstract]  
Fair Value Measurements NOTE 10. FAIR VALUE MEASUREMENTS

We measure certain financial assets and liabilities at fair value on a recurring basis. Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants, under a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:

Level 1 - inputs to the valuation methodology are quoted market prices for identical assets or liabilities in active markets.

Level 2 - inputs to the valuation methodology include quoted prices in markets that are not active or model inputs that are

observable either directly or indirectly for substantially the full term of the asset or liability.

Level 3 - inputs to the valuation methodology are based on prices or valuation techniques that are unobservable.

Assets and liabilities measured at fair value on a recurring basis at June 30, 2022 and December 31, 2021 were as follows:

June 30, 2022

Level 1

Level 2

Level 3

Total

Assets

Designated forward exchange contracts

$

-

$

1,605

$

-

$

1,605

$

-

$

1,605

$

-

$

1,605

Liabilities

Undesignated commodity derivative contracts

$

553

$

-

$

-

$

553

Contingent consideration liabilities

-

-

3,652

3,652

$

553

$

-

$

3,652

$

4,205

December 31, 2021

Level 1

Level 2

Level 3

Total

Assets

Designated forward exchange contracts

$

-

$

511

$

-

$

511

$

-

$

511

$

-

$

511

Liabilities

Designated forward exchange contracts

$

-

$

24

$

-

$

24

Contingent consideration liabilities

-

-

3,485

3,485

$

-

$

24

$

3,485

$

3,509

Derivative financial instruments are recorded at fair value based on current market pricing models. No nonrecurring fair value measurements existed at June 30, 2022 and December 31, 2021.  

The Company estimated the fair value of contingent consideration liabilities primarily using a series of call options or other valuation methodologies. Significant unobservable inputs used in the valuation include discount rates ranging from 4.8% to 8.0%. Contingent consideration liabilities are remeasured at the estimated fair value at the end of each reporting period with the change in fair value recognized in contingent consideration expense (benefit) in the accompanying condensed consolidated statements of comprehensive income for such period. We measure the initial liability and remeasure the liability on a recurring basis using Level 3 inputs as defined under authoritative guidance for fair value measurements.

The net sales threshold required for the payment of the Rhino-Rack Contingent Consideration was not met during the measurement period ended June 30, 2022. The net sales threshold required for the payment of the 2022 portion of the MAXTRAX Contingent Consideration was met during the 2022 measurement period ended June 30, 2022. Subsequent to June 30, 2022, $AUD 3,125 (approximately $2,148) was paid in cash in accordance with the MAXTRAX Purchase Agreement.

The following table summarizes the changes in contingent consideration liabilities:

Rhino-Rack

MAXTRAX

Total

Balance at December 31, 2021

$

1,813

$

1,672

$

3,485

Fair value adjustments

(1,810)

2,199

389

Impact of foreign currency exchange rates

(3)

(219)

(222)

Balance at June 30, 2022

$

-

$

3,652

$

3,652

As the contingent consideration liabilities are remeasured to fair value each reporting period, significant increases or decreases in projected sales, discount rates or the time until payment is made would have resulted in a significantly lower or higher fair value measurement. Our determination of fair value of the contingent consideration liabilities could change in future periods based on our ongoing evaluation of these significant unobservable inputs.